{"entity":{"type":"insider","cik":"0001774690","url":"/insider/0001774690","json_url":"/insider/0001774690.json","name":"Leggett Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":6,"first":"2020-09-16","last":"2026-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Leggett Thomas","source":"filing","n_filings":6,"first_seen":"2020-09-16","last_seen":"2026-03-19"}],"transactions":[{"id":5828920,"accession":"0001774690-26-000006","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001774690-26-000006","line_url":"/filing/0001774690-26-000006#line-5","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2173.0,"shares_display":"2,173","price_per_share":31.2838,"price_display":"31.28","price_state":"stated","total_value":67979.6974,"total_display":"67,979.70","shares_owned_after":10381.0,"shares_owned_after_display":"10,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":5828918,"accession":"0001774690-26-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001774690-26-000006","line_url":"/filing/0001774690-26-000006#line-4","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":172.0,"shares_display":"172","price_per_share":31.7888,"price_display":"31.79","price_state":"stated","total_value":5467.6736,"total_display":"5,467.67","shares_owned_after":10209.0,"shares_owned_after_display":"10,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":5828916,"accession":"0001774690-26-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001774690-26-000006","line_url":"/filing/0001774690-26-000006#line-3","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37.0,"shares_display":"37","price_per_share":32.85,"price_display":"32.85","price_state":"stated","total_value":1215.45,"total_display":"1,215.45","shares_owned_after":10172.0,"shares_owned_after_display":"10,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":5828915,"accession":"0001774690-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001774690-26-000006","line_url":"/filing/0001774690-26-000006#line-2","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1274.0,"shares_display":"1,274","price_per_share":32.7394,"price_display":"32.74","price_state":"stated","total_value":41709.9956,"total_display":"41,710.00","shares_owned_after":13476.0,"shares_owned_after_display":"13,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":5828912,"accession":"0001774690-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001774690-26-000006","line_url":"/filing/0001774690-26-000006#line-1","is_derivative":false,"issuer_cik":"0001623526","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001623526","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":922.0,"shares_display":"922","price_per_share":33.3754,"price_display":"33.38","price_state":"stated","total_value":30772.1188,"total_display":"30,772.12","shares_owned_after":12554.0,"shares_owned_after_display":"12,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":5363091,"accession":"0000899243-21-001378","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-001378","line_url":"/filing/0000899243-21-001378#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":33.94,"price_display":"33.94","price_state":"stated","total_value":101820.0,"total_display":"101,820.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-11","scope":"insider"},{"id":2733090,"accession":"0000899243-20-033341","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-033341","line_url":"/filing/0000899243-20-033341#line-3","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1941.0,"shares_display":"1,941","price_per_share":34.0514,"price_display":"34.05","price_state":"stated","total_value":66093.7674,"total_display":"66,093.77","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-08","filed_date":"2020-12-10","scope":"insider"},{"id":2733085,"accession":"0000899243-20-033341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-033341","line_url":"/filing/0000899243-20-033341#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1059.0,"shares_display":"1,059","price_per_share":33.2701,"price_display":"33.27","price_state":"stated","total_value":35233.0359,"total_display":"35,233.04","shares_owned_after":1941.0,"shares_owned_after_display":"1,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-08","filed_date":"2020-12-10","scope":"insider"},{"id":2248971,"accession":"0000899243-20-030831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030831","line_url":"/filing/0000899243-20-030831#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":32.9639,"price_display":"32.96","price_state":"stated","total_value":98891.7,"total_display":"98,891.70","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-12","scope":"insider"},{"id":2329481,"accession":"0000899243-20-027904","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-027904","line_url":"/filing/0000899243-20-027904#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":33.5253,"price_display":"33.53","price_state":"stated","total_value":100575.9,"total_display":"100,575.90","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-08","filed_date":"2020-10-09","scope":"insider"},{"id":2784705,"accession":"0000899243-20-025360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-025360","line_url":"/filing/0000899243-20-025360#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001774690","owner_name":"Leggett Thomas","owner_url":"/insider/0001774690","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":31.0,"price_display":"31.00","price_state":"stated","total_value":93000.0,"total_display":"93,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001623526","name":"Stoke Therapeutics, Inc.","url":"/issuer/0001623526","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2026-03-19","last_seen":"2026-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001701541","name":"Black Diamond Therapeutics, Inc.","url":"/issuer/0001701541","role":"Officer (Chief Financial Officer)","n_filings":5,"first_seen":"2020-09-16","last_seen":"2021-01-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001774690","retrieved_at":"2026-08-22T01:26:12+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}